医学
缺血性中风
血管内治疗
冲程(发动机)
临床试验
急性中风
重症监护医学
外科
内科学
组织纤溶酶原激活剂
缺血
机械工程
工程类
动脉瘤
作者
Nazli Janjua,Jonathan L. Brisman
标识
DOI:10.1016/s1474-4422(07)70269-7
摘要
The emphasis of treatments for acute ischaemic stroke during the past two decades has been on revascularisation. Endovascular treatment is a promising alternative for patients who are ineligible for standard intravenous thrombolytic therapy; however, its use is limited by the few randomised trials reported and the small number of practising neurointerventionalists. Although data are still being collected, important progress has been made. In this Review, we summarise the findings of the major clinical trials of endovascular treatment, and show that endovascular treatment of acute ischaemic stroke is a therapeutic option for patients who are disqualified from or do not improve on treatment with intravenous alteplase. Moreover, the American Heart Association has expanded its guidelines to include endovascular stroke therapies as a treatment option.
科研通智能强力驱动
Strongly Powered by AbleSci AI